This report aims to provide a comprehensive presentation of the global market for Cancers Immunotherapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancers Immunotherapy Drugs. This report contains market size and forecasts of Cancers Immunotherapy Drugs in global, including the following market information:
Global Cancers Immunotherapy Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancers Immunotherapy Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancers Immunotherapy Drugs include Roche, Pfizer, Merck, Novartis, Johnson & Johnson, Sanofi, GlaxoSmithKline, Amgen and AbbVie, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancers Immunotherapy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancers Immunotherapy Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancers Immunotherapy Drugs Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Check Point Inhibitors
Interferons
Interleukins
Global Cancers Immunotherapy Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancers Immunotherapy Drugs Market Segment Percentages, by Application, 2022 (%)
Lung Cancer
Liver Cancer
Colorectal Cancer
Pancreatic Cancer
Breast Cancer
Other Cancers
Global Cancers Immunotherapy Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancers Immunotherapy Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancers Immunotherapy Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancers Immunotherapy Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Pfizer
Merck
Novartis
Johnson & Johnson
Sanofi
GlaxoSmithKline
Amgen
AbbVie
Boehringer Ingelheim
AstraZeneca
Immatics Biotechnologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancers Immunotherapy Drugs, market overview.
Chapter 2: Global Cancers Immunotherapy Drugs market size in revenue.
Chapter 3: Detailed analysis of Cancers Immunotherapy Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancers Immunotherapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancers Immunotherapy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancers Immunotherapy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancers Immunotherapy Drugs Overall Market Size
2.1 Global Cancers Immunotherapy Drugs Market Size: 2022 VS 2029
2.2 Global Cancers Immunotherapy Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancers Immunotherapy Drugs Players in Global Market
3.2 Top Global Cancers Immunotherapy Drugs Companies Ranked by Revenue
3.3 Global Cancers Immunotherapy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Cancers Immunotherapy Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancers Immunotherapy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancers Immunotherapy Drugs Players in Global Market
3.6.1 List of Global Tier 1 Cancers Immunotherapy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancers Immunotherapy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancers Immunotherapy Drugs Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Check Point Inhibitors
4.1.4 Interferons
4.1.5 Interleukins
4.2 By Type - Global Cancers Immunotherapy Drugs Revenue & Forecasts
4.2.1 By Type - Global Cancers Immunotherapy Drugs Revenue, 2018-2023
4.2.2 By Type - Global Cancers Immunotherapy Drugs Revenue, 2024-2029
4.2.3 By Type - Global Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancers Immunotherapy Drugs Market Size, 2022 & 2029
5.1.2 Lung Cancer
5.1.3 Liver Cancer
5.1.4 Colorectal Cancer
5.1.5 Pancreatic Cancer
5.1.6 Breast Cancer
5.1.7 Other Cancers
5.2 By Application - Global Cancers Immunotherapy Drugs Revenue & Forecasts
5.2.1 By Application - Global Cancers Immunotherapy Drugs Revenue, 2018-2023
5.2.2 By Application - Global Cancers Immunotherapy Drugs Revenue, 2024-2029
5.2.3 By Application - Global Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancers Immunotherapy Drugs Market Size, 2022 & 2029
6.2 By Region - Global Cancers Immunotherapy Drugs Revenue & Forecasts
6.2.1 By Region - Global Cancers Immunotherapy Drugs Revenue, 2018-2023
6.2.2 By Region - Global Cancers Immunotherapy Drugs Revenue, 2024-2029
6.2.3 By Region - Global Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancers Immunotherapy Drugs Revenue, 2018-2029
6.3.2 US Cancers Immunotherapy Drugs Market Size, 2018-2029
6.3.3 Canada Cancers Immunotherapy Drugs Market Size, 2018-2029
6.3.4 Mexico Cancers Immunotherapy Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancers Immunotherapy Drugs Revenue, 2018-2029
6.4.2 Germany Cancers Immunotherapy Drugs Market Size, 2018-2029
6.4.3 France Cancers Immunotherapy Drugs Market Size, 2018-2029
6.4.4 U.K. Cancers Immunotherapy Drugs Market Size, 2018-2029
6.4.5 Italy Cancers Immunotherapy Drugs Market Size, 2018-2029
6.4.6 Russia Cancers Immunotherapy Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Cancers Immunotherapy Drugs Market Size, 2018-2029
6.4.8 Benelux Cancers Immunotherapy Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancers Immunotherapy Drugs Revenue, 2018-2029
6.5.2 China Cancers Immunotherapy Drugs Market Size, 2018-2029
6.5.3 Japan Cancers Immunotherapy Drugs Market Size, 2018-2029
6.5.4 South Korea Cancers Immunotherapy Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Cancers Immunotherapy Drugs Market Size, 2018-2029
6.5.6 India Cancers Immunotherapy Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancers Immunotherapy Drugs Revenue, 2018-2029
6.6.2 Brazil Cancers Immunotherapy Drugs Market Size, 2018-2029
6.6.3 Argentina Cancers Immunotherapy Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancers Immunotherapy Drugs Revenue, 2018-2029
6.7.2 Turkey Cancers Immunotherapy Drugs Market Size, 2018-2029
6.7.3 Israel Cancers Immunotherapy Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Cancers Immunotherapy Drugs Market Size, 2018-2029
6.7.5 UAE Cancers Immunotherapy Drugs Market Size, 2018-2029
7 Cancers Immunotherapy Drugs Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Cancers Immunotherapy Drugs Major Product Offerings
7.1.4 Roche Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Cancers Immunotherapy Drugs Major Product Offerings
7.2.4 Pfizer Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Cancers Immunotherapy Drugs Major Product Offerings
7.3.4 Merck Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Cancers Immunotherapy Drugs Major Product Offerings
7.4.4 Novartis Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Cancers Immunotherapy Drugs Major Product Offerings
7.5.4 Johnson & Johnson Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Cancers Immunotherapy Drugs Major Product Offerings
7.6.4 Sanofi Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Cancers Immunotherapy Drugs Major Product Offerings
7.7.4 GlaxoSmithKline Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 Amgen
7.8.1 Amgen Company Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Cancers Immunotherapy Drugs Major Product Offerings
7.8.4 Amgen Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.8.5 Amgen Key News & Latest Developments
7.9 AbbVie
7.9.1 AbbVie Company Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Cancers Immunotherapy Drugs Major Product Offerings
7.9.4 AbbVie Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.9.5 AbbVie Key News & Latest Developments
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Company Summary
7.10.2 Boehringer Ingelheim Business Overview
7.10.3 Boehringer Ingelheim Cancers Immunotherapy Drugs Major Product Offerings
7.10.4 Boehringer Ingelheim Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.10.5 Boehringer Ingelheim Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Business Overview
7.11.3 AstraZeneca Cancers Immunotherapy Drugs Major Product Offerings
7.11.4 AstraZeneca Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.11.5 AstraZeneca Key News & Latest Developments
7.12 Immatics Biotechnologies
7.12.1 Immatics Biotechnologies Company Summary
7.12.2 Immatics Biotechnologies Business Overview
7.12.3 Immatics Biotechnologies Cancers Immunotherapy Drugs Major Product Offerings
7.12.4 Immatics Biotechnologies Cancers Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.12.5 Immatics Biotechnologies Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancers Immunotherapy Drugs Market Opportunities & Trends in Global Market
Table 2. Cancers Immunotherapy Drugs Market Drivers in Global Market
Table 3. Cancers Immunotherapy Drugs Market Restraints in Global Market
Table 4. Key Players of Cancers Immunotherapy Drugs in Global Market
Table 5. Top Cancers Immunotherapy Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancers Immunotherapy Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancers Immunotherapy Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancers Immunotherapy Drugs Product Type
Table 9. List of Global Tier 1 Cancers Immunotherapy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancers Immunotherapy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancers Immunotherapy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancers Immunotherapy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancers Immunotherapy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancers Immunotherapy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancers Immunotherapy Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancers Immunotherapy Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Cancers Immunotherapy Drugs Product Offerings
Table 32. Roche Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Cancers Immunotherapy Drugs Product Offerings
Table 36. Pfizer Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Cancers Immunotherapy Drugs Product Offerings
Table 40. Merck Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Cancers Immunotherapy Drugs Product Offerings
Table 44. Novartis Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Cancers Immunotherapy Drugs Product Offerings
Table 48. Johnson & Johnson Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Cancers Immunotherapy Drugs Product Offerings
Table 52. Sanofi Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Cancers Immunotherapy Drugs Product Offerings
Table 56. GlaxoSmithKline Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. Amgen Company Summary
Table 59. Amgen Cancers Immunotherapy Drugs Product Offerings
Table 60. Amgen Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Amgen Key News & Latest Developments
Table 62. AbbVie Company Summary
Table 63. AbbVie Cancers Immunotherapy Drugs Product Offerings
Table 64. AbbVie Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. AbbVie Key News & Latest Developments
Table 66. Boehringer Ingelheim Company Summary
Table 67. Boehringer Ingelheim Cancers Immunotherapy Drugs Product Offerings
Table 68. Boehringer Ingelheim Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Boehringer Ingelheim Key News & Latest Developments
Table 70. AstraZeneca Company Summary
Table 71. AstraZeneca Cancers Immunotherapy Drugs Product Offerings
Table 72. AstraZeneca Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. AstraZeneca Key News & Latest Developments
Table 74. Immatics Biotechnologies Company Summary
Table 75. Immatics Biotechnologies Cancers Immunotherapy Drugs Product Offerings
Table 76. Immatics Biotechnologies Cancers Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Immatics Biotechnologies Key News & Latest Developments
List of Figures
Figure 1. Cancers Immunotherapy Drugs Segment by Type in 2022
Figure 2. Cancers Immunotherapy Drugs Segment by Application in 2022
Figure 3. Global Cancers Immunotherapy Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancers Immunotherapy Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancers Immunotherapy Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancers Immunotherapy Drugs Revenue in 2022
Figure 8. By Type - Global Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 16. US Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 28. China Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancers Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancers Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sanofi Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GlaxoSmithKline Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Amgen Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. AbbVie Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Boehringer Ingelheim Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. AstraZeneca Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Immatics Biotechnologies Cancers Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
